Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding

C. W. Francis, V. J. Marder, C. M. Evarts and S. Yaukoolbodi

In a randomized, prospective trial of 100 patients, we have studied the safety and efficacy of warfarin sodium in comparison with that of dextran 40 in the prevention of venous thrombosis in patients at high risk for deep vein thrombosis after elective total hip or knee replacement. Warfarin was given in a new two-step regimen designed to avoid bleeding complications while still preventing venous thrombosis. A low dose of warfarin was started ten to 14 days preoperatively, and the prothrombin time was regulated to between 1.5 and 3 seconds longer than control at the time of surgery; immediately after surgery, the dose was increased to prolong the prothrombin time to 1.5 times control. The overall incidence of venous thrombosis as documented by venography was less in the 53 patients treated with warfarin than in the 37 treated with dextran (21% v 51%), as was the incidence of thrombi in the femoral or popliteal veins (2% v 16%). Objective measures of blood loss showed no difference between patients treated with warfarin or dextran, and excessive postoperative bleeding was infrequent and similar in both treatment groups. This study demonstrates that two-step warfarin therapy provides highly effective prophylaxis of postoperative venous thrombosis after elective hip or knee prosthetic surgery without excessive risk of perioperative bleeding.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Feasibility Study of Continuing Dose-Reduced Warfarin for Invasive Procedures in Patients With High Thromboembolic Risk
Larson et al.
Chest 2005;127:922-927.
ABSTRACT | FULL TEXT  

Anti-Xa and Anti-IIa Drugs Alter International Normalized Ratio Measurements: Potential Problems in the Monitoring of Oral Anticoagulants
Tobu et al.
CLIN APPL THROMB HEMOST 2004;10:301-309.
ABSTRACT  

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy
Hirsh et al.
J Am Coll Cardiol 2003;41:1633-1652.
FULL TEXT  

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
Hirsh et al.
Circulation 2003;107:1692-1711.
FULL TEXT  

Minidose Warfarin Prophylaxis for Catheter-Associated Thrombosis in Cancer Patients: Can It Be Safely Associated With Fluorouracil-Based Chemotherapy?
Masci et al.
JCO 2003;21:736-739.
ABSTRACT | FULL TEXT  

Thrombotic Disorders: Diagnosis and Treatment
Schafer et al.
ASH Education Book 2003;2003:520-539.
ABSTRACT | FULL TEXT  

Timing of Initial Administration of Low-Molecular-Weight Heparin Prophylaxis Against Deep Vein Thrombosis in Patients Following Elective Hip Arthroplasty: A Systematic Review
Hull et al.
Arch Intern Med 2001;161:1952-1960.
ABSTRACT | FULL TEXT  

Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association
Hirsh et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21 :e9-e9.
FULL TEXT  

Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association
Hirsh et al.
Circulation 2001;103:2994-3018.
FULL TEXT  

Prevention of Venous Thromboembolic Disease Following Primary Total Knee Arthroplasty : A Randomized, Multicenter, Open-Label, Parallel-Group Comparison of Enoxaparin and Warfarin
Fitzgerald et al.
JBJS 2001;83:900-906.
ABSTRACT | FULL TEXT  

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
Hirsh et al.
Chest 2001;119:8S-21S.
FULL TEXT  

Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
Hirsh et al.
Chest 2001;119:64S-94S.
FULL TEXT  

Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers et al.
Chest 2001;119:176S-193S.
FULL TEXT  

A Meta-Analysis of Thromboembolic Prophylaxis Following Elective Total Hip Arthroplasty
Freedman et al.
JBJS 2000;82:929-929.
ABSTRACT | FULL TEXT  

A Stuck PigEven on WarfarinDoesn't Always Bleed
Kitchens
Chest 1999;115:1492-1493.
FULL TEXT  

Prevention of Deep-Vein Thrombosis after Total Hip Arthroplasty. Comparison of Warfarin and Dalteparin
FRANCIS et al.
JBJS 1997;79:1365-72.
ABSTRACT | FULL TEXT  

Management of Anticoagulation before and after Elective Surgery
Kearon and Hirsh
NEJM 1997;336:1506-1511.
FULL TEXT  

Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Common Complications of Total Knee Arthroplasty*{{dagger}}
AYERS et al.
JBJS 1997;79:278-311.
FULL TEXT  

State-of-the-Art Review : Prevention of Venous Thromboembolism in Major Orthopedic Surgery
Prandoni et al.
CLIN APPL THROMB HEMOST 1996;2:153-157.
ABSTRACT  

Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association
Hirsh and Hoak
Circulation 1996;93:2212-2245.
FULL TEXT  

Minidose Warfarin and Failure to Prevent Deep Vein Thrombosis After Joint Replacement Surgery Despite Inhibiting the Postoperative Rise in Plasminogen Activator Inhibitor Activity
Poller et al.
CLIN APPL THROMB HEMOST 1995;1:267-273.
ABSTRACT  

A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation
Hull et al.
NEJM 1993;329:1370-1376.
ABSTRACT | FULL TEXT  

Duplex Ultrasonography for the Detection of Deep Vein Thrombi After Total Hip or Knee Arthroplasty
Elliott et al.
ANGIOLOGY 1993;44:26-33.
ABSTRACT  

Deep Venous Thrombosis and Pulmonary Embolism in Trauma Patients
Shackford and Moser
J Intensive Care Med 1988;3:87-98.
ABSTRACT